Cationic nanoparticles with quaternary ammonium-functionalized PLGA-PEG-based copolymers for potent gene transfection

Journal of Nanoparticle Research

Volumn 15, Issue 11, 2013, Pages

  Wang, Yan Hsung ^a   Fu, Yin Chih ^b,c,d   Chiu, Hui Chi ^a   Wang, Chau Zen ^b   Lo, Shao Ping ^a   Ho, Mei Ling ^b   Liu, Po Len ^b   Wang, Chih Kuang ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Cationic copolymer; Gene transfection; Nanomedicine; Nanoparticle; Poly(lactic co glycolic acid); Quaternary ammonium

Indexed keywords

AMINO ACIDS; GENE TRANSFER; GENES; LIPOSOMES; MEDICAL NANOTECHNOLOGY; MOLECULAR BIOLOGY; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYETHYLENES; STEM CELLS;

CATIONIC COPOLYMER; GENE TRANSFECTION; HETEROBIFUNCTIONAL POLYETHYLENE GLYCOLS; HUMAN ADIPOSE DERIVED STEM CELLS; POLY LACTIC-CO-GLYCOLIC ACID; QUATERNARY AMMONIUM; QUATERNARY AMMONIUM SALT; WATER-MISCIBLE SOLVENTS;

POLYETHYLENE OXIDES;

AMMONIA; COPOLYMER; DIETHYLENETRIAMINE; MACROGOL; NANOPARTICLE; PLASMID DNA; POLYGLACTIN; QUATERNARY AMMONIUM DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DNA BINDING; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS; ZETA POTENTIAL;

EID: 84886890292     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-2077-4     Document Type: Article

References (51)

1. Ambegia E, Ansell S, Cullis P, Heyes J, Palmer L, MacLachlan I (2005) Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Biochim Biophys Acta 1669(2):155-163
2. Ando S, Putnam D, Pack DW, Langer R (1999) PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 88(1):126-130
3. Antipina MN, Dobner B, Konovalov OV, Shapovalov VL, Brezesinski G (2007) Investigation of the protonation state of novel cationic lipids designed for gene transfection. J Phys Chem B 111(49):13845-13850
4. Banerjee SR, Levadala MK, Lazarova N, Wei L, Valliant JF, Stephenson KA, Babich JW, Maresca KP, Zubieta J (2002) Bifunctional single amino acid chelates for labeling of biomolecules with the [Tc(CO)(3)](+) and [Re(CO)(3)](+) cores. Crystal and molecular structures of [ReBr(CO)(3) (H(2)NCH(2)C(5)H(4)N)], [Re(CO)(3)[(C(5)H(4)NCH(2)) (2)NH]]Br, [Re(CO)(3)[(C(5)H(4)NCH(2))(2)NCH(2)CO(2) H]]Br, [Re(CO)(3)[X(Y)NCH(2)CO(2)CH(2)CH(3)]]Br (X = Y = 2-pyridylmethyl; X = 2-pyridylmethyl, Y = 2-(1-methylimidazolyl)methyl; X = Y = 2-(1- methylimidazolyl) methyl), [ReBr(CO)(3)[(C(5)H(4)NCH(2)) NH(CH(2)C(4)H(3)S)]], and [Re(CO)(3)[(C(5)H(4) NCH(2))N(CH(2)C(4)H(3)S)(CH(2)CO(2))]]. Inorg Chem 41(24):6417-6425
5. Bivas-Benita M, Romeijn S, Junginger HE, Borchard G (2004) PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm 58(1):1-6
6. Boddu S, Vaishya R, Jwala J, Vadlapudi A, Pal D, Mitra A (2012) Preparation and characterization of folate conjugated nanoparticles of doxorubicin using PLGA-PEG-FOL polymer. Med Chem 2:068-075
7. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92(16):7297-7301
8. Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP (1999) Preparation and characterization of poly(D,L-lactide-coglycolide) microspheres for controlled release of poly(Llysine) complexed plasmid DNA. Pharm Res 16(4):509-513
9. Cheng TL, Cheng CM, Chen BM, Tsao DA, Chuang KH, Hsiao SW, Lin YH, Roffler SR (2005)Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles. Bioconjug Chem 16(5): 1225-1231
10. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC (2007) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28(5):869-876
11. Desai MP, Labhasetwar V, Amidon GL, Levy RJ (1996) Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13(12):1838-1845
12. Duncan R (2006) Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6(9):688-701
13. Florence AT, Hillery AM, Hussain N, Jani PU (1995) Nanoparticles as carriers for oral peptide absorption - studies on particle uptake and fate. J Controlled Release 36(1-2): 39-46
14. Gao X, Kim KS, Liu D (2007) Nonviral gene delivery: what we know and what is next. AAPS J 9(1):E92-E104
15. Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y (2008) Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules 9(2):435-443
16. Ho ML, Fu YC, Wang GJ, Chen HT, Chang JK, Tsai TH, Wang CK (2008) Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Controlled Release 128(2):142-148
17. Huang Z, Li W, MacKay JA, Szoka FC Jr (2005) Thiocholesterol-based lipids for ordered assembly of bioresponsive gene carriers. Mol Ther 11(3):409-417
18. Jang JH, Lim KI, Schaffer DV (2007) Library selection and directed evolution approaches to engineering targeted viral vectors. Biotechnol Bioeng 98(3):515-524
19. Kang SW, Lim HW, Seo SW, Jeon O, Lee M, Kim BS (2008) Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 29(8):1109-1117
20. Kim YH, Gihm SH, Park CR, Lee KY, Kim TW, Kwon IC, Chung H, Jeong SY (2001) Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjug Chem 12(6):932-938
21. Kodama K, Katayama Y, Shoji Y, Nakashima H (2006) The features and shortcomings for gene delivery of current nonviral carriers. Curr Med Chem 13(18):2155-2161
22. Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ (1998) Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 87(10):1229-1234
23. Li SD, Huang L (2006) Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther 13(18):1313-1319
24. Li Z, Ning W, Wang J, Choi A, Lee PY, Tyagi P, Huang L (2003) Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm Res 20(6):884-888
25. Lim YB, Choi YH, Park JS (1999) A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester). J Am Chem Soc 121(24):5633-5639
26. Locatelli E, Franchini MC (2012) Biodegradable PLGA- b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system. J Nanopart Res 14(12):1316-1333
27. MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP (1998) Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Controlled Release 56(1-3):259-272
28. Mateos-Timoneda MA, Lok MC, Hennink WE, Feijen J, Engbersen JF (2008) Poly(amido amine)s as gene delivery vectors: effects of quaternary nicotinamide moieties in the side chains. Chem Med Chem 3(3):478-486
29. Nie H, Ho ML, Wang CK, Wang CH, Fu YC (2009) BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials 30(5):892-901
30. Ohlfest JR, Lobitz PD, Perkinson SG, Largaespada DA (2004) Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system. Mol Ther 10(2):260-268
31. Ohlfest JR, Freese AB, Largaespada DA (2005) Nonviral vectors for cancer gene therapy: prospects for integrating vectors and combination therapies. Curr Gene Ther 5(6):629-641
32. Palmer DH, Young LS, Mautner V (2006) Cancer gene-therapy: clinical trials. Trends Biotechnol 24(2):76-82
33. Pamujula S, Graves RA, Moiseyev R, Bostanian LA, Kishore V, Mandal TK (2008) Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation. J Pharm Pharmacol 60(3):283-289
34. Peetla C, Labhasetwar V (2009) Effect of molecular structure of cationic surfactants on biophysical interactions of surfac-tant- modified nanoparticles with a model membrane and cellular uptake. Langmuir 25(4):2369-2377
35. Peracchia MT, Harnisch S, Pinto-Alphandary H, Gulik A, Dedieu JC, Desmaele D, d'Angelo J, Muller RH, Couvreur P (1999) Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials 20(14):1269-1275
36. Perumal OP, Inapagolla R, Kannan S, Kannan RM (2008) The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials 29(24-25):3469-3476
37. Petros RA, DeSimone JM (2010) Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9(8):615-627
38. Piest M, Engbersen JF (2010) Effects of charge density and hydrophobicity of poly(amido amine)s for non-viral gene delivery. J Controlled Release 148(1):83-90
39. Prabha S, Labhasetwar V (2004) Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol Pharm 1(3):211-219
40. Prabha S, Zhou WZ, Panyam J, Labhasetwar V (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 244(1-2):105-115
41. Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VH (2004) The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res 21(4):641-648
42. Rabinovich-Guilatt L, Couvreur P, Lambert G, Dubernet C (2004) Cationic vectors in ocular drug delivery. J Drug Target 12(9-10):623-633
43. Singh M, Briones M, Ott G, O'Hagan D (2000) Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97(2):811-816
44. Son S, Kim WJ (2009) Biodegradable nanoparticles modified by branched polyethyleneimine for plasmid DNA delivery. Biomaterials 31(1):133-143
45. Song LY, Ahkong QF, Rong Q, Wang Z, Ansell S, Hope MJ, Mui B (2002) Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 1558(1):1-13
46. van den Berg JH, Oosterhuis K, Hennink WE, Storm G, van der Aa LJ, Engbersen JF, Haanen JB, Beijnen JH, Schumacher TN, Nuijen B (2009) Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity. J Controlled Release 141(2):234-240
47. Vercauteren D, Rejman J, Martens TF, Demeester J, De Smedt SC, Braeckmans K (2012) On the cellular processing of non-viral nanomedicines for nucleic acid delivery: mechanisms and methods. J Controlled Release 161(2):566-581
48. Verma IM, Somia N (1997) Gene therapy-promises, problems and prospects. Nature 389(6648):239-242
49. Wang CK, Ho ML, Wang GJ, Chang JK, Chen CH, Fu YC, Fu HH (2009) Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials 30(25):4178-4186
50. Wetzer B, Byk G, Frederic M, Airiau M, Blanche F, Pitard B, Scherman D (2001) Reducible cationic lipids for gene transfer. Biochem J 356(Pt 3):747-756
51. Yue ZG, Wei W, Lv PP, Yue H, Wang LY, Su ZG, Ma GH (2011) Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12(7):2440-2446